Sign up Australia
Proactive Investors - Run By Investors For Investors

BioTech Capital signs strategic agreement with Swedish medtech player

The company has won the rights to distribute two dental products.
A dentist working on a patient
BioTech’s shares were last trading 11% higher intra-day

BioTech Capital Limited’s (ASX:BTC) wholly owned subsidiary BioImpact has extended its exclusive license and supply agreement with RLS Global AB to include two additional products.

BioTech is in the business of providing development capital and management expertise to high-growth Australian biotech, medtech and pharmaceutical companies.

RLS Global is a Swedish medtech company that develops and sells biochemical products and methods for the treatment of some of the world’s most common diseases.

BioImpact has won the rights to distribute RLS Global’s two dental products Perisolv and Carisolv within Australia, New Zealand and select countries across the Asia Pacific region.

Perisolv is a patented and biochemically active gel that optimises the dental professional’s treatment of advanced gum disorders like periodontitis, mucositis and peri-implantitis.

The gel when applied directly exerts a bacteriostatic effect and aids in dissolving degenerated tissue, making the debridement easier for both dental professionals and patients.

Carisolv is a patented gel that assists in the removal and treatment of dental caries. It is a minimally invasive treatment that gives better bonding strength to the filling.

Perisolv and Carisolv are classified as medical devices to be made available in Australia this financial year post inclusion in the Australian Register of Therapeutic Goods.

BioTech’s shares were last trading 11% higher intra-day, at $0.20.

View full BTC profile View Profile

Biotech Capital Ltd Timeline

Newswire
February 13 2017
Newswire
August 07 2014

Related Articles

Blood cells
October 12 2017
Current standard of care treatment involves chemotherapy and radiotherapy and ultimately, in recurring cases, a bone marrow transplant
cannabis plant
February 02 2018
Today, the group closed the US$18mln acquisition of Citiva Medical and Citiva USA
Internet TV specialsit Falcon Media House transformed and ready to start generating revenues
August 26 2017
It has gone from a cash shell to fully fledged online TV company plugged into a massive market in a year and half

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use